MentionFox
Home › 5%+ stakes › Manufacturing, latest filing in January 2026
5%+ stakes

Manufacturing, latest filing in January 2026

16 companies with 5%+ holders, every filing linked: Anixa Biosciences, Inc., Blue Line Holdings, Inc., Broadwind, Inc., Cvd Equipment Corp, Dror Ortho-Design, Inc., Ericsson Lm Telephone Co and more. Each section is the company's full record from its filings, newest filings first within each section.

16 companies with 5%+ holders on this page (Manufacturing, latest filing in January 2026), each linked to its filing, starting with Anixa Biosciences, Inc., Blue Line Holdings, Inc., Broadwind, Inc.. Free check on any of them: https://mentionfox.com/check

On this page

Anixa Biosciences, Inc.

At 5% or more1
Filings1
Latest filing2026-01-06

Anixa Biosciences, Inc. has 1 Schedule 13D or 13G filing on record since 2026-01-06. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Michael Catelani7%2,468,103SCHEDULE 13D/A, 2026-01-062026-01-05
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Michael Catelani2,468,10302,468,1030SCHEDULE 13D/A, 2026-01-06

The latest filing identifies Anixa Biosciences, Inc. by CUSIP 03528H109 and gives its principal executive office as 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA 95118 (SCHEDULE 13D/A, 2026-01-06).

FiledHolderPercentFiling
2026-01-06Michael Catelani7%SCHEDULE 13D/A

Blue Line Holdings, Inc.

At 5% or more1
Filings1
Latest filing2026-01-14

Blue Line Holdings, Inc. has 1 Schedule 13D or 13G filing on record since 2026-01-14. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Joseph C. Henn50.4%5,100,000SCHEDULE 13D, 2026-01-142025-12-08
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Joseph C. Henn5,100,00005,100,0000SCHEDULE 13D, 2026-01-14

The latest filing identifies Blue Line Holdings, Inc. by CUSIP 956871091 and gives its principal executive office as 18 Lakewood Blvd., Lynbrook, NY 11563 (SCHEDULE 13D, 2026-01-14).

The amount of funds used in making the purchase: $5,100 The funds used in making the purchase were the personal funds of Mr. Henn. Mr. Henn replaced the Company's former CEO and Director and purchased the shares owned by the former CEO and Director.Joseph C. Henn, SCHEDULE 13D, 2026-01-14

Joseph C. Henn

NoItem 4 of the SCHEDULE 13D filed 2026-01-14
FiledHolderPercentFiling
2026-01-14Joseph C. Henn50.4%SCHEDULE 13D
DateRecordFigureOur pageSource
July 11, 2025Form D, private offering$5K soldForm D pageSource
May 7, 2025Form D, private offering$103K soldForm D pageSource

Broadwind, Inc.

At 5% or more2
Filings2
Latest filing2026-01-27

Broadwind, Inc. has 2 Schedule 13D or 13G filings on record since 2025-11-14. 2 holders' latest filing reports 5% or more of common stock $0.001 par value. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Grace & White, Inc8.8%2,042,554SCHEDULE 13G/A, 2026-01-272025-12-31
Delaware Charter Guarantee & Trust Company dba Principal Trust Company as Directed Trustee for the Broadwind, Inc. Employees' 401(k)7.3%1,669,405SCHEDULE 13G, 2025-11-142025-11-14
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Grace & White, Inc519,11802,042,5540SCHEDULE 13G/A, 2026-01-27
Delaware Charter Guarantee & Trust Company dba Principal Trust Company as Directed Trustee for the Broadwind, Inc. Employees' 401(k)01,669,40501,669,405SCHEDULE 13G, 2025-11-14

The latest filing names Broadwind, Inc., with its principal executive office as 3240 S. Central Avenue, Cicero, IL 60804 (SCHEDULE 13G/A, 2026-01-27).

FiledHolderPercentFiling
2025-11-14Delaware Charter Guarantee & Trust Company dba Principal Trust Company as Directed Trustee for the Broadwind, Inc. Employees' 401(k)7.3%SCHEDULE 13G
2026-01-27Grace & White, Inc8.8%SCHEDULE 13G/A
DateRecordFigureOur pageSource
October 30, 2026Acquired MCM Acquisition Company Inc.$18MAcquisitionSource

Cvd Equipment Corp

At 5% or more1
Filings1
Latest filing2026-01-21

Cvd Equipment Corp has 1 Schedule 13D or 13G filing on record since 2026-01-21. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Layoffs on record: 1 filing or notice, latest 2026-09-10 (layoff filings and notices).

HolderPercentSharesLatestEvent date
Leviticus Partners LP5%345,873SCHEDULE 13G/A, 2026-01-212026-01-16
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Leviticus Partners LP345,8730345,8730SCHEDULE 13G/A, 2026-01-21

The latest filing names Cvd Equipment Corp, with its principal executive office as 355 S. TECHNOLOGY DRIVE, CENTRAL ISLIP, NJ 11722 (SCHEDULE 13G/A, 2026-01-21).

FiledHolderPercentFiling
2026-01-21Leviticus Partners LP5%SCHEDULE 13G/A
DateRecordFigureOur pageSource
September 10, 2026Leadership change: Warren Cheesman appointed, Chief Executive Officer—Leadership changesSource

Dror Ortho-Design, Inc.

At 5% or more1
Filings1
Latest filing2026-01-29

Dror Ortho-Design, Inc. has 1 Schedule 13D or 13G filing on record since 2026-01-29. 1 holder's latest filing reports 5% or more of common stock, $0.0001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Orin Hirschman9.9%95,662,500SCHEDULE 13G/A, 2026-01-292025-12-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Orin Hirschman95,662,500095,662,5000SCHEDULE 13G/A, 2026-01-29
AIGH Capital Management LLC87,000,000087,000,0000SCHEDULE 13G/A, 2026-01-29

The latest filing names Dror Ortho-Design, Inc., with its principal executive office as Shatner Street 3, Jerusalem (SCHEDULE 13G/A, 2026-01-29).

FiledHolderPercentFiling
2026-01-29Orin Hirschman9.9%SCHEDULE 13G/A

Ericsson Lm Telephone Co

At 5% or more1
Filings1
Latest filing2026-01-21

Ericsson Lm Telephone Co has 1 Schedule 13D or 13G filing on record since 2026-01-21. 1 holder's latest filing reports 5% or more of class b stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
BlackRock, Inc.5.1%159,358,047SCHEDULE 13G, 2026-01-212025-12-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
BlackRock, Inc.143,946,2110159,358,0470SCHEDULE 13G, 2026-01-21

The latest filing names Ericsson Lm Telephone Co, with its principal executive office as TORSHAMNSGATAN 21 - 23, Stockholm (SCHEDULE 13G, 2026-01-21).

FiledHolderPercentFiling
2026-01-21BlackRock, Inc.5.1%SCHEDULE 13G

Espey Mfg & Electronics Corp

At 5% or more1
Filings1
Latest filing2026-01-26

Espey Mfg & Electronics Corp has 1 Schedule 13D or 13G filing on record since 2026-01-26. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Espey Mfg. & Electronics Corp. Employee Retirement Plan & Trust18%537,345SCHEDULE 13G/A, 2026-01-262025-12-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Espey Mfg. & Electronics Corp. Employee Retirement Plan & Trust189,817537,345189,817537,345SCHEDULE 13G/A, 2026-01-26

The latest filing names Espey Mfg & Electronics Corp, with its principal executive office as 233 BALLSTON AVE, SARATOGA SPRINGS, NY 12866 (SCHEDULE 13G/A, 2026-01-26).

FiledHolderPercentFiling
2026-01-26Espey Mfg. & Electronics Corp. Employee Retirement Plan & Trust18%SCHEDULE 13G/A

Ferrari N.V.

At 5% or more1
Filings1
Latest filing2026-01-06

Ferrari N.V. has 1 Schedule 13D or 13G filing on record since 2026-01-06. 1 holder's latest filing reports 5% or more of common shares, par value euro 0.01 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Exor N.V.21.3%37,768,613SCHEDULE 13D/A, 2026-01-062026-01-03
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Exor N.V.37,768,613037,768,6130SCHEDULE 13D/A, 2026-01-06
Piero Ferrari18,894,295000SCHEDULE 13D/A, 2026-01-06
Trust Piero Ferrari00018,894,295SCHEDULE 13D/A, 2026-01-06
Enzo Mattioli Ferrari, in his capacity as a trustee00018,894,295SCHEDULE 13D/A, 2026-01-06
Franco Ravanetti, in his capacity as a guardian00018,894,295SCHEDULE 13D/A, 2026-01-06

The latest filing identifies Ferrari N.V. by CUSIP N3167Y103 and gives its principal executive office as Via Abetone Inferiore n. 4, Maranello (MO) (SCHEDULE 13D/A, 2026-01-06).

Exor N.V.

Item 4 is hereby amended and supplemented to include the following: The information set forth in Item 6 hereof is hereby incorporated by reference into this Item 4.Item 4 of the SCHEDULE 13D/A filed 2026-01-06
FiledHolderPercentFiling
2026-01-06Exor N.V.21.3%SCHEDULE 13D/A

Graphjet Technology

At 5% or more1
Filings2
Latest filing2026-01-30

Graphjet Technology has 2 Schedule 13D or 13G filings on record since 2025-11-14. 1 holder's latest filing reports 5% or more of class a ordinary shares, par value $0.006 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
The Goldman Sachs Group, Inc.5.6%227,486SCHEDULE 13G/A, 2026-01-302025-12-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
The Goldman Sachs Group, Inc.0227,4860227,486SCHEDULE 13G/A, 2026-01-30
Goldman Sachs & Co. LLC0227,4860227,486SCHEDULE 13G/A, 2026-01-30

The latest filing names Graphjet Technology, with its principal executive office as Lot 3895, Lorong 6D, Kampung Baru Subang, Seksyen U6, Shah Alam, Selangor (SCHEDULE 13G/A, 2026-01-30).

FiledHolderPercentFiling
2025-11-14The Goldman Sachs Group, Inc.7.2%SCHEDULE 13G
2026-01-30The Goldman Sachs Group, Inc.5.6%SCHEDULE 13G/A

Lyra Therapeutics, Inc.

At 5% or more1
Filings6
Latest filing2026-01-20

Lyra Therapeutics, Inc. has 6 Schedule 13D or 13G filings on record since 2025-08-14. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

Layoffs on record: 1 filing or notice, latest 2026-01-12 (layoff filings and notices).

HolderPercentSharesLatestEvent date
Sabby Management, LLC9.9%175,158SCHEDULE 13G, 2026-01-202025-12-31
Perceptive Advisors LLC0%0SCHEDULE 13D/A, 2025-11-252025-11-21
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Sabby Management, LLC0175,1580175,158SCHEDULE 13G, 2026-01-20
Hal Mintz0175,1580175,158SCHEDULE 13G, 2026-01-20
Sabby Volatility Warrant Master Fund, Ltd.0175,1580175,158SCHEDULE 13G, 2026-01-20
Perceptive Advisors LLC0000SCHEDULE 13D/A, 2025-11-25
Joseph Edelman0000SCHEDULE 13D/A, 2025-11-25
Perceptive Life Sciences Master Fund, Ltd.0000SCHEDULE 13D/A, 2025-11-25
Perceptive LS (A), LLC0000SCHEDULE 13D/A, 2025-11-25

The latest filing names Lyra Therapeutics, Inc., with its principal executive office as 480 ARSENAL WAY, WATERTOWN, MA 02472 (SCHEDULE 13G, 2026-01-20).

FiledHolderPercentFiling
2025-08-14Perceptive Advisors LLC15.55%SCHEDULE 13D/A
2025-11-10Perceptive Advisors LLC11.2%SCHEDULE 13D/A
2025-11-13Perceptive Advisors LLC7.8%SCHEDULE 13D/A
2025-11-18Perceptive Advisors LLC5.5%SCHEDULE 13D/A
2025-11-25Perceptive Advisors LLC0%SCHEDULE 13D/A
2026-01-20Sabby Management, LLC9.9%SCHEDULE 13G

Microbot Medical Inc.

At 5% or more1
Filings5
Latest filing2026-01-23

Microbot Medical Inc. has 5 Schedule 13D or 13G filings on record since 2025-07-29. 1 holder's latest filing reports 5% or more of common stock, par value $0.01 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Mitchell P. Kopin8.2%6,002,185SCHEDULE 13G, 2026-01-232026-01-15
The Vanguard Group4.45%2,343,561SCHEDULE 13G/A, 2025-10-312025-09-30
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Mitchell P. Kopin06,002,18506,002,185SCHEDULE 13G, 2026-01-23
Daniel B. Asher06,002,18506,002,185SCHEDULE 13G, 2026-01-23
Intracoastal Capital LLC06,002,18506,002,185SCHEDULE 13G, 2026-01-23
The Vanguard Group0260,6692,062,921280,640SCHEDULE 13G/A, 2025-10-31

The latest filing names Microbot Medical Inc., with its principal executive office as 175 Derby St., Bld. 27, Hingham, MA 02043 (SCHEDULE 13G, 2026-01-23).

FiledHolderPercentFiling
2025-07-29The Vanguard Group5.63%SCHEDULE 13G
2025-08-12Mitchell P. Kopin9.99%SCHEDULE 13G/A
2025-10-31The Vanguard Group4.45%SCHEDULE 13G/A
2025-11-07Mitchell P. Kopin0%SCHEDULE 13G/A
2026-01-23Mitchell P. Kopin8.2%SCHEDULE 13G
DateRecordFigureOur pageSource
August 7, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
September 30, 2025Form D, private offering$25.24M soldForm D pageSource
February 18, 2025Form D, private offering$13M soldForm D pageSource
January 22, 2025Form D, private offering$7M soldForm D pageSource
January 22, 2025Form D, private offering$8.60M soldForm D pageSource

Natural Alternatives International Inc

At 5% or more1
Filings1
Latest filing2026-01-21

Natural Alternatives International Inc has 1 Schedule 13D or 13G filing on record since 2026-01-21. 1 holder's latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Dimensional Fund Advisors LP6.2%384,497SCHEDULE 13G/A, 2026-01-212025-12-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Dimensional Fund Advisors LP379,5480384,4970SCHEDULE 13G/A, 2026-01-21

The latest filing names Natural Alternatives International Inc, with its principal executive office as 1185 Linda Vista Drive, San Marcos (SCHEDULE 13G/A, 2026-01-21).

FiledHolderPercentFiling
2026-01-21Dimensional Fund Advisors LP6.2%SCHEDULE 13G/A
DateRecordFigureOur pageSource
May 1, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource

NIO Inc.

At 5% or more1
Filings2
Latest filing2026-01-13

NIO Inc. has 2 Schedule 13D or 13G filings on record since 2026-01-08. 1 holder's latest filing reports 5% or more of class a ordinary shares, par value $0.00025 per share. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
CYVN Investments RSC Ltd17.9%418,833,157SCHEDULE 13D/A, 2026-01-132026-01-12
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
CYVN Investments RSC Ltd418,833,1570418,833,1570SCHEDULE 13D/A, 2026-01-13
L'imad Holding Company - P.J.S.C418,833,1570418,833,1570SCHEDULE 13D/A, 2026-01-13

The latest filing identifies NIO Inc. by CUSIP 62914V106 and gives its principal executive office as Building 19, No. 1355, Caobao Road, Minhang District, Shanghai (SCHEDULE 13D/A, 2026-01-13).

FiledHolderPercentFiling
2026-01-08CYVN Investments RSC Ltd17.9%SCHEDULE 13D/A
2026-01-13CYVN Investments RSC Ltd17.9%SCHEDULE 13D/A

Oragenics Inc

At 5% or more2
Filings2
Latest filing2026-01-21

Oragenics Inc has 2 Schedule 13D or 13G filings on record since 2025-07-02. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Five Narrow Lane LP9.99%82,210SCHEDULE 13G, 2025-07-022025-07-02
Sabby Management, LLC9.9%412,654SCHEDULE 13G, 2026-01-212025-12-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Five Narrow Lane LP82,210082,2100SCHEDULE 13G, 2025-07-02
Sabby Management, LLC0412,6540412,654SCHEDULE 13G, 2026-01-21
Hal Mintz0412,6540412,654SCHEDULE 13G, 2026-01-21
Sabby Volatility Warrant Master Fund, Ltd.0412,6540412,654SCHEDULE 13G, 2026-01-21

The latest filing names Oragenics Inc, with its principal executive office as 9015 TOWN CENTER PARKWAY, SUITE 143, LAKEWOOD RANCH, FL 34202 (SCHEDULE 13G, 2026-01-21).

FiledHolderPercentFiling
2025-07-02Five Narrow Lane LP9.99%SCHEDULE 13G
2026-01-21Sabby Management, LLC9.9%SCHEDULE 13G
DateRecordFigureOur pageSource
July 6, 2026Leadership change: John Spencer appointed, Chief Financial Officer—Leadership changesSource

Sigyn Therapeutics, Inc.

At 5% or more1
Filings1
Latest filing2026-01-14

Sigyn Therapeutics, Inc. has 1 Schedule 13D or 13G filing on record since 2026-01-14. 1 holder's latest filing reports 5% or more of common stock, par value $0.0001. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
Brio Capital Master Fund Ltd.9.99%160,537SCHEDULE 13G/A, 2026-01-142025-12-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
Brio Capital Master Fund Ltd.160,5370160,5370SCHEDULE 13G/A, 2026-01-14
Brio Capital Management LLC160,5370160,5370SCHEDULE 13G/A, 2026-01-14

The latest filing names Sigyn Therapeutics, Inc., with its principal executive office as 2468 Historic Decatur Road, Ste. 140, San Diego, CA 92106 (SCHEDULE 13G/A, 2026-01-14).

FiledHolderPercentFiling
2026-01-14Brio Capital Master Fund Ltd.9.99%SCHEDULE 13G/A

Xbiotech Inc.

At 5% or more2
Filings2
Latest filing2026-01-23

Xbiotech Inc. has 2 Schedule 13D or 13G filings on record since 2026-01-23. 2 holders' latest filing reports 5% or more of common shares, no par value. Each figure below is the holder's own, as filed, with the filing linked.

HolderPercentSharesLatestEvent date
John Simard17.7%5,719,775SCHEDULE 13G/A, 2026-01-232025-12-31
W. Thorpe McKenzie9.76%3,006,259SCHEDULE 13G/A, 2026-01-232025-12-31
Reporting personSole votingShared votingSole dispositiveShared dispositiveFiling
John Simard5,719,77505,719,7750SCHEDULE 13G/A, 2026-01-23
W. Thorpe McKenzie2,899,971106,2882,899,971106,288SCHEDULE 13G/A, 2026-01-23

The latest filing names Xbiotech Inc., with its principal executive office as 5217 Winnebago Ln, Austin, TX (SCHEDULE 13G/A, 2026-01-23).

FiledHolderPercentFiling
2026-01-23John Simard17.7%SCHEDULE 13G/A
2026-01-23W. Thorpe McKenzie9.76%SCHEDULE 13G/A
DateRecordFigureOur pageSource
October 26, 2026Leadership change: Sushma Shivaswamy appointed, Chief Executive Officer, and 1 more—Leadership changesSource

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All 5%+ stakes

RSS